| Abstract|| |
Introduction: Multidrug-resistant Acinetobacter baumannii is galloping, posing threat to tackle, and leaving us with limited options of treatment. Methods: The purpose of this study is to find the genotypic association in drug-resistant A. baumannii isolated from different sterile body fluids. Matrix-assisted laser desorption/ionization–time of flight confirmed A. baumannii isolates were taken and minimum inhibitory concentration (MIC) was determined by VITEK-2 AST system. The presence of resistance nodulation–division (RND)-efflux pump genes AdeABC-RS was detected by multiplex polymerase chain reaction. Results: Of the total 40 A. baumannii, 32 (80%) were multidrug resistant though all isolates were susceptible to Tigecycline. Similarly, 26 (81.25%) isolates were positive for RND-efflux pump genes AdeABC-RS. Discussion: RND efflux pump AdeABC-RS system plays a significant role in emerging multi drug resistant A. baumannii. Mutation in AdeS gene deciphers the role of regulatory gene. Hence, antimicrobial stewardship should be strictly followed and efflux pump inhibiting substances should be vigorously searched to bring back the era of existing antibiotics.
Keywords: Acinetobacter baumannii, regulatory system, resistance nodulation–cell division-efflux pump, sterile body fluids
|How to cite this article:|
Raza S, Gautam H, Mohapatra S, Sood S, Dhawan B, Chaudhry R, Kapil A, Das BK. Molecular characterization of resistance-nodulation-cell division efflux pump genes in multidrug-resistant Acinetobacter baumannii. J Global Infect Dis 2021;13:177-9
|How to cite this URL:|
Raza S, Gautam H, Mohapatra S, Sood S, Dhawan B, Chaudhry R, Kapil A, Das BK. Molecular characterization of resistance-nodulation-cell division efflux pump genes in multidrug-resistant Acinetobacter baumannii. J Global Infect Dis [serial online] 2021 [cited 2022 Jan 25];13:177-9. Available from: https://www.jgid.org/text.asp?2021/13/4/177/329794
| Introduction|| |
Acinetobacter baumannii is an opportunistic pathogen responsible for various infections. Over the last 30 years, A. baumannii has dramatically developed resistance to the most widely used drugs and listed in the red line of the most rapidly replicated bacteria as per the World Health Organization. Efflux pump plays a pivotal role, especially in the multidrug resistant (MDR) non fermentative bacteria. A. baumannii show intrinsic MDR to an array of antibiotics due to chromosomally encoded enzymes and an innate efflux pump expression. A. baumannii mutate quickly to acquire new mechanism of resistance. The most clinically relevant efflux pump system belongs to resistance nodulation–division (RND) super family. This study was designed to look for the RND efflux pump gene and its expression in MDR A. baumannii.
| Methods|| |
A cross-sectional study was conducted in the Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India, from September 2019 to February 2020. A total of 40 isolates of A. baumannii were collected from different sterile body fluids (i.e. cerebrospinal fluid [CSF], Pleural fluid, Ascitic fluid and Broncho-alveolar lavage) and confirmed by matrix assisted laser desorption/ionization–time of flight (MALDI-TOF). Minimum inhibitory concentration (MIC) of the antibiotics was determined by VITEK-2 AST system (Biomerieux, France). In addition, broth microdilution (BMD) was performed for colistin using double strength cation-adjusted Mueller Hinton broth. Control strains, Escherichia coli ATCC 25922 (MIC QC range 0.25–2 μg/ml for colistin) and Pseudomonas aeruginosa ATCC 27853 (MIC QC range 0.5–4 μg/ml for colistin), were used as per CLSI guideline 2019. To observe the effect of efflux pump inhibitor (EPI) Carbonyl cyanide-m chlorophenylhydrazone (CCCP), it was added to Muller Hinton agar (MHA) Plate and final concentration of CCCP (Sigma Aldrich, USA) in MHA was adjusted 15 μg/ml. Bacteria were grown on MHA with CCCP and MIC was determined by VITEK-2 AST system. DNA was extracted from all the isolates by QIAamp DNA mini extraction Kit (Qiagen, USA) and multiplex polymerase chain reaction (PCR) was performed for detection of RND efflux pump gene AdeABC as well as Regulatory components AdeRS. The standard strains of A. baumannii ATCC 19606 was used as positive control. Cycling condition used for multiplex PCR was, initial denaturation 94°C for 10 min, denaturation at 94°C for 1 min, annealing at 57°C for 30 s, extension at 72°C for 1 min and final extension was at 72°C for 7 min. Total numbers of cycle were 35. Agarose gel images of multiplex PCR product of RND efflux pump genes AdeBC and Regulatory genes AdeRS are shown in [Figure 1] and [Figure 2].
|Figure 1: Showing gel image of polymerase chain reaction product of AdeB and C gene. Well 1 showing 100 bp ladder, 2 Negative control, 3 A. baumannii ATCC 19606 positive control, 5 only AdeC gene, 6,7,10,12,14 B gene and well 13 showing AdeBC gene|
Click here to view
|Figure 2: Showing gel image of polymerase chain reaction product of AdeRS gene. Well 1 100bp ladder, 2 A. baumannii ATCC 19606 positive control, 6 Negative control, 3, 4, 5, 7, 8, 9 and 10 AdeRS gene and 11, 12 showing only AdeS gene|
Click here to view
Sequencing of 14 PCR products of four isolates were done, analyzed by Chromas version 2.6.4., and was deposited in NCBI for accession number. Accession numbers given were from MT912014-MT912027 for different genes of RND efflux pump.
| Results|| |
The mean age of the patients was 40.27 ± 6.27 years (Min 3–Max 93 years). Total 40 isolates collected from different sterile body fluid and were confirmed by MALDI-TOF. Of the total, 14 (35%) from CSF, 14 (35%) from pleural fluid, 8 (20%) from Ascitic fluid and 4 (10%) from Peritoneal fluid were taken respectively. Of the total, 32 (80%) isolates were resistant to three or more drugs of different antimicrobial groups. Similarly, out of 32 isolates, 25 (78.13%) were extensively drug resistant. Among the MDR, 23 (71.87%) isolates were resistant to amikacin and gentamicin. In addition, the most effective antibiotic was tigecycline (No resistance, Food and Drug Administration interpretive criteria of tigecycline for Enterobacteriaceae were used as EUCAST version 11.0, 2021 mentions insufficient evidence) followed by trimethoprim 14 (35%). For colistin, BMD was performed, out of 40 isolates, 3 isolates showed resistance to colistin in which MIC value was observed >4 μg/ml.
Similarly, due to effect of EPI, carbonyl cyanide 3-chlorophenylhydrazone (CCCP), 10 (25%) isolates showed 2–64 fold reductions in MIC values for different antibiotics. Change in MIC value after addition of EPI is shown in [Table 1].
|Table 1: Multidrug resistant isolates of Acinetobacter baumannii showing 2-64 folds reduction in minimum inhibitory concentration value in the presence of an efflux pump inhibitor|
Click here to view
In case of colistin, out of 3 resistance strains, 8-fold reductions in MIC value were observed in 2 strains. Likewise, 26 (65%) isolates were positive for either of the AdeABC or AdeRS gene. AdeB was detected in most of the isolates, 15 (57.69%) followed by AdeA in 13 (50%). Sequencing analysis result showed mutation (Accession No. MT912022) at (L172P) position in RND–efflux pump regulatory gene AdeS.
| Discussion|| |
Globally, it is confirmed from various reports that A. baumannii is difficult to treat as it has various virulence factors and genes that is responsible for antimicrobial resistance. Our study showed 80% resistance to carbapenem (imipenem). Y Chen et al. from china had shown 78.2% resistance to imipenem which is concurrent to our finding. Similarly, tigecycline was found most susceptible antibiotic, result is concordance with the finding of Y Chen et al. and Lin L et al. who found antibiotic susceptibility profile that advocates the limited drug choices in A. baumannii therapy.
We have found decrease in MIC value of various antibiotics after addition of proton ionosphere compound CCCP. Similar reduction in MIC for various antibiotics has been reported in other studies. This infers the involvement of efflux system in these isolates showing high resistance to various antibiotics. RND efflux pump in bacteria is driven primarily by the physiological functions and not by the selective pressure imposed due to the use of antibiotics and are assumed to be highly conserved in bacterial genome. Few studies have considered sequence conservation of gene encoding efflux pump at the strain level.,
Till date, over expression of RND systems i.e. AdeABC, AdeFGH and AdeIJK has been associated with multidrug resistance in A. baumannii. However, AdeABC strongly confers resistance to different group of drugs and reduced susceptibility to tigecycline.,, In our study, resistance up to 80% for most of the antibiotics was observed. Out of 32 MDR isolates, 26 (81.25%) were positive for AdeABC-RS system. Finding of this study is concurrent to the finding of Lin L et al. that had shown AdeABC-RS in 70% of the MDR isolates. It suggests a potential linkage between these genes and multidrug resistance. The strain, in which mutation was found, was MDR though susceptible to tigecycline. Many authors have depicted the mutation in AdeS gene in tigecycline-susceptible strains.
| Conclusion|| |
A. baumannii have developed resistance to most of the commonly used antibiotics. RND-efflux pump has emerged as one of the newest bacterial resistance mechanism. Hence, new arsenal in the form of EPI need to be developed that will be useful to restore the fundamental action of antibiotics as well as to counter act the Global challenge of controlling the spreading of multi drug resistant A. baumannii strain.
Research quality and ethics statement
This study was approved by the Institutional Review Board / Ethics Committee (IEC 773). The authors followed applicable EQUATOR Network (“http:// www.equator-network.org/) guidelines during the conduct of this research project.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 2015;13:42-51.
Coyne S, Courvalin P, Périchon B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 2011;55:947-53.
Croft AC, D'Antoni AV, Terzulli SL. Update on the antibacterial resistance crisis. Med Sci Monit 2007;13:A103-18.
Chen Y, Ai L, Guo P, Huang H, Wu Z, Liang X, et al
. Molecular characterization of multidrug resistant strains of Acinetobacter baumannii
isolated from pediatric intensive care unit in a Chinese tertiary hospital. BMC Infect Dis 2018;18:614.
Lin L, Ling BD, Li XZ. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK
, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii
-Acinetobacter calcoaceticus complex. Int J Antimicrob Agents 2009;33:27-32.
Osei Sekyere J, Amoako DG. Carbonyl Cyanide m-Chlorophenylhydrazine (CCCP) Reverses resistance to colistin, but not to carbapenems and tigecycline in multidrug-resistant Enterobacteriaceae
. Front Microbiol 2017;8:228.
Chan BK, Sistrom M, Wertz JE, Kortright KE, Narayan D, Turner PE. Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
. Sci Rep 2016;6:26717.
Pao SS, Paulsen IT, Saier MH Jr., Major facilitator superfamily. Microbiol Mol Biol Rev 1998;62:1-34.
Peleg AY, Adams J, Paterson DL. Tigecycline efflux as a mechanism for non susceptibility in Acinetobacter baumannii
. Antimicrob Agents Chemother 2007;51:2065-9.
Ruzin A, Immermann FW, Bradford PA. RT-PCR and statistical analyses of adeABC expression in clinical isolates of Acinetobacter calcoaceticus
complex. Microb Drug Resist 2010;16:87-9.
Ruzin A, Keeney D, Bradford PA. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus
complex. J Antimicrob Chemother 2007;59:1001-4.
Yoon EJ, Courvalin P, Grillot-Courvalin C. RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii
: Major role for AdeABC overexpression and AdeRS mutations. Antimicrob Agents Chemother 2013;57:2989-95.
Dr. Hitender Gautam
Associate Professor Department of Microbiology, All India Institute of Medical Sciences, New Delhi
Source of Support: None, Conflict of Interest: None
[Figure 1], [Figure 2]